1Cappell MS, Schein JR. Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity.Gastroenterol Clin North Am, 2000, 29: 97-124.
2Seager JM, Hawkey CJ. ABC of the upper gastrointestinal tract.Indigestion and non-steroidal anti-inflammatory drugs. BMJ, 2001,323 : 1236-1239.
3Lanas A, Hirschowitz BI. Toxicity of NSAIDs in the stomach and duodenum. EurJ Gastroenterol Hepatol, 1999, 11:375-381.
5Champion GD, Feng PH, Azuma T, et al. NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacific perspective and consensus. Drugs, 1997, 53: 6-19.
6McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definition and epidemiology. Am J Med,1998,105:3S-9S.
7Bjorkman DJ. Current status of nonsteroidal anti-inflammatory drug(NSAID) use in the United States: Risk factors and frequency of complications. Am J Med, 1999, 107: 3S-10S.
8Garcia-Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet, 1994, 343 : 769-772.
9Hemandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation. Arch Intern Med, 2000, 160: 2093-2099.
10Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy.Gastroenterology, 2000, 119 : 521-535.
2Suriya C, Kasatpibal N, Kunaviktikul W, et al. Diagnostic indicators for peptic ulcer perforation at a tertiary care hospital in Thailand. Clin Exp Gastroenterol, 2011, 4 : 283-289.
